Skip to content

13F-HR filed by Knoll Capital Management, LLC

Knoll Capital Management, LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 36 holding rows worth $153,726,702.

Accession
0001104659-25-049384
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 36 entries on the cover page, a total value of $153,726,702 stated on the cover page (in dollars after the unit check, H1), rows summing to $153,726,702 with VALUE read as dollars as filed, 13F file number 028-11424. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALDEYRA THERAPEUTICS INC01438T106COM5,475,516$31,484,217dollars as filed
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM830,879$19,974,331dollars as filed
ENTERA BIO LTDM40527109SHS5,881,879$9,999,194dollars as filed
SPDR GOLD TR78463V107GOLD SHS32,000$9,220,480dollars as filed
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK1,250,000$8,475,000dollars as filed
AGNICO EAGLE MINES LTD COM008474108Stock55,500$6,016,755dollars as filed
ALTIMMUNE INC02155H200COM NEW1,121,524$5,607,620dollars as filed
KINROSS GOLD CORP496902404COM440,000$5,548,400dollars as filed
Sandstorm Gold Ltd80013R206Common Stock700,000$5,285,000dollars as filed
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO600,000$4,698,000dollars as filed
OCULAR THERAPEUTIX INC67576A100COM600,400$4,400,932dollars as filed
FRANCO NEV CORP COM351858105Stock25,000$3,939,000dollars as filed
Elicio Therapeutics Inc Com28657F103LST Equity Option630,915$3,886,436dollars as filed
Applied Therapeutics Inc03828A101Common Stock7,799,687$3,806,247dollars as filed
EQUINOX GOLD CORP29446Y502COM550,811$3,789,579dollars as filed
SEABRIDGE GOLD INC811916105COM *D*317,003$3,699,425dollars as filed
SKEENA RES LTD NEW83056P715COM315,400$3,182,386dollars as filed
MAG SILVER CORP55903Q104COMMON STOCK-FO170,000$2,597,600dollars as filed
iShares Silver Trust46428Q109COM80,000$2,479,200dollars as filed
NUVATION BIO INC COM CL A67080N101Stock1,025,000$1,804,000dollars as filed
Visa Inc92826C839COM4,850$1,699,731dollars as filed
Philip Morris International Inc.718172109COM10,000$1,587,300dollars as filed
BOOZ ALLEN HAMILTON HLDG CORP CL A099502106Stock13,000$1,359,540dollars as filed
ROYAL GOLD INC780287108COM7,550$1,234,500dollars as filed
iShares U.S. Aerospace & Defense ETF464288760SHS7,650$1,171,215dollars as filed
NORTHROP GRUMMAN CORP COM666807102Stock2,165$1,108,501dollars as filed
ALAMOS GOLD INC COM CL A011532108Stock41,000$1,096,340dollars as filed
WHEATON PRECIOUS METALS CORP COM962879102Stock12,500$970,375dollars as filed
DIAGEO PLC SPON ADR NEW25243Q205ADR6,750$707,332dollars as filed
MEREO BIOPHARMA GROUP PLC589492107CMN260,470$586,058dollars as filed
COEUR MNG INC COM NEW192108504Stock96,132$569,101dollars as filed
HOOKIPA PHARMA INC43906K100COM498,625$538,515dollars as filed
NEW PAC METALS CORP64782A107COM485,000$535,925dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS7,049$447,541dollars as filed
Orgenesis, Inc.68619K105COM50,623$124,026dollars as filed
CARDIOL THERAPEUTICS INC14161Y200COM CL A100,000$96,900dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-25-049384this filing2025-05-15acceptance time not in the bulk data set